517 0 Kommentare Hydropothecary Closes Offering of Convertible Debenture Units for $69 Million

GATINEAU, QC--(Marketwired - November 24, 2017) -

NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES.

The Hydropothecary Corporation ("THCX" or the "Company") (TSX VENTURE: THCX) is pleased to announce it has closed its previously disclosed bought deal public offering (the "Offering") of convertible debenture units of the Company (the "Units") for aggregate gross proceeds of $69 million. The Offering was underwritten by a syndicate of underwriters led by Canaccord Genuity Corp. and including Beacon Securities Limited, Cormark Securities Inc., Echelon Wealth Partners Inc., Eight Capital and PI Financial Corp. (collectively, the "Underwriters").

Under the Offering, the Company issued 69,000 Units at a price of $1,000 per Unit, including 9,000 Units issued pursuant to the exercise in full of the over-allotment option the Company granted to the Underwriters in connection with the Offering. Each Unit consists of $1,000 principal amount of 7.0% unsecured convertible debentures of the Company (the "Convertible Debentures") and 227 common share purchase warrants (the "Warrants") of the Company.

"With this new financing in place, and the progress of our current expansion on track, we are positioned to become an industry-leading cannabis products company," said Sébastien St-Louis, Co-founder and CEO. "As we move forward, our shareholders can take confidence in our commitment to continuously lowering our production costs; to driving product innovation; and, to producing quality products in response to customer demand," concluded Mr. St-Louis.

The Convertible Debentures bear interest from the date of closing at 7.0% per annum, payable semiannually on June 30 and December 31 of each year and will mature on November 24, 2020. The Convertible Debentures are convertible at the option of the holder into common shares of the Company ("Common Shares") at any time prior to the close of business on the maturity date at a conversion price of $2.20 per share (the "Conversion Price"). The Company may force the conversion of all of the principal amount of the then outstanding Convertible Debentures at the Conversion Price on 30 days' written notice should the daily volume weighted average trading price of the Common Shares be greater than $3.15 for any 10 consecutive trading days.